Table I.
PID | Gene / protein mutated | Inheritance | Age at presentation of warts | Types / Location of warts | Other Infections | Other clinical associations | Immune phenotype |
---|---|---|---|---|---|---|---|
| |||||||
Epidermodysplasia Verruciformis | EVER1 and 2 / epidermodysplasia verruciformis 1 and 2 | AR Reports of XL and AD |
Infancy | Flat – trunk, neck, extremities Verrucous – sun exposed areas Hypo /hyper pigmented lesions resembling pityriasis versicolor | 30-70% lesions undergo malignant transformation |
|
|
| |||||||
WHIM | CXCR4 / chemokine receptor 4 | AD | Variable | Flat, verrucous – extremities, trunk Verrucous - genital | Pneumonia, Cellulitis, Sinusitis, UTI, Thrombophlebitis, Omphalitis, Osteomyelitis, Soft tissue abscesses, HSV, VZV |
|
|
| |||||||
DOCK8 | DOCK8 / DOCK8 | AR | Variable | Flat, verrucous – trunk, face, extremities | S. aureus skin abscesses, Pneumonia, Sinusitis, Soft tissue infections, HSV, MCV, VZV | Eczema, Food allergies, Asthma, Lymphoreticular and squamous cell malignancies |
|
| |||||||
ICL | Unknown | ? | Late adolescence, adult | Flat, verrucous – face, trunk, extremities Verrucous -genital | Opportunistic infections – MAC, Cryptococcus, histoplasmosis, Mucocutaneous Candida, HSV, P. Jirovecii rare | Autoimmune disease |
|
Autoantibodies | |||||||
Mucocutaneous | |||||||
Squamous cell cancer | |||||||
| |||||||
GATA2 deficiency | GATA2/GATA2 binding protein | AD | Late adolescence / adult | Flat, verrucous – face, trunk, extremities, disseminated, genital | NTM | Myelodysplasia, leukemias, Malignancy Panniculitis Thromboembolic phenomena Pulmonary alveolar proteinosis Lymphedema |
|
MonoMAC | Histoplasma | ||||||
DCML | Aspergillus | ||||||
Emberger syndrome | Cryptococcus | ||||||
VZV | |||||||
HSV | |||||||
| |||||||
Netherton Syndrome | SPINK5 / LEKTI | AR | Adolescence, adulthood | Common, plane – extremities, trunk Verrucous -genital | Cellulitis | Bamboo hair |
|
Bacteremia | Icthyosis | ||||||
Cutaneous HSV | Eczema | ||||||
Food allergies | |||||||
Asthma | |||||||
| |||||||
STK4 Deficiency | STK4 / STK4 or MST1 | AR | Unknown | Cutaneous | Cellulitis | Autoimmunity |
|
Skin Abscesses | EBV related malignancy | ||||||
Pneumonia | Structural heart disease | ||||||
Sinusitis | |||||||
HSV | |||||||
VZV | |||||||
MCV | |||||||
EBV |
AR, autosomal recessive; AD, autosomal dominant; XL, X-linked; LPM, lymphocyte proliferation to mitogen; WHIM, warts, hypogammaglobulinemia, infections, myelokathexis; UTI, urinary tract infection; HSV, herpes simplex virus; VZV, varicella zoster virus; Ig –G, -A, -M, -E, -D, immunoglobulin –G, -A, -M, -E, -D; LPA, lymphocyte proliferation to antigen; DOCK8, dedicator of cytokinesis 8; MCV, molluscum cantagiosum virus; ICL, Idiopathic CD4 lymphopenia; MAC, Mycobacterium avium complex; MonoMAC, monocytopenia, M. avium complex infection; DCML, dendritic cell, monocyte, B cell and NK cell lymphopenia; NTM, nontuberculous mycobacteria; SPINK5, serine protease inhibitor Kazal-type 5; LEKTI, lympho-epithelial Kazal-type related inhibitor; STK4, serine-threonine protein kinase 4; MST1, mammalian sterile 20-like protein; EBV, Epstein-Barr virus.